To strengthen its position as an international contract manufacturing organization (CMO) in China, Wuxi Griffin has established a new quality control (QC) lab and storage facility. The new QC lab is a fully equipped microbiology and analytical testing lab for bulk and final product testing—final sterility testing, one of the most critical testing stages, is done in an isolator.
 
The new storage facility offers a dry and clean storage area that can fit 72 pallets. The warehouse has a class C sampling room with a laminar flow bench sampling area to accommodate the needs for a sampling environment.
 
Several storage conditions are available:
 
• Room temperate for normal storage conditions with temperatures around the range of 20° to 25°C (68 – 77°F);
• Cold storage with temperature range between 8 to 15°C (46.4 – 59°F); and
• Frozen storage at -80°C (equivalent to -112°F).
 
“These strategic investments demonstrates above all Wuxi Griffin’s commitment to its CMO business,” said Torgny Lundgren, chief executive officer, Wuxi Griffin. “By investing in business growth and advancements, Wuxi Griffin is able to attract and foster new talents. This is essential for the future development of Wuxi Griffin. Moreover, offering the right strategic capabilities and services, will most importantly lead to continued growth. Being at the forefront of the growth in this industry and region, is important to us. This will also benefit the final consumers and patients who will have access to safe and available injectables.”